KR960010617A - 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 - Google Patents

신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 Download PDF

Info

Publication number
KR960010617A
KR960010617A KR1019940022798A KR19940022798A KR960010617A KR 960010617 A KR960010617 A KR 960010617A KR 1019940022798 A KR1019940022798 A KR 1019940022798A KR 19940022798 A KR19940022798 A KR 19940022798A KR 960010617 A KR960010617 A KR 960010617A
Authority
KR
South Korea
Prior art keywords
structural formula
following structural
represented
phenylalaninol
carbamoyl
Prior art date
Application number
KR1019940022798A
Other languages
English (en)
Other versions
KR100197892B1 (ko
Inventor
변재국
최용문
Original Assignee
조규향
주식회사 유공
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1019940022798A priority Critical patent/KR100197892B1/ko
Application filed by 조규향, 주식회사 유공 filed Critical 조규향
Priority to ES95931444T priority patent/ES2140703T3/es
Priority to RU96113126/04A priority patent/RU2104266C1/ru
Priority to PCT/KR1995/000114 priority patent/WO1996007637A1/en
Priority to EP95931444A priority patent/EP0728129B1/en
Priority to JP8509386A priority patent/JP2680478B2/ja
Priority to US08/619,657 priority patent/US5955499A/en
Priority to CN95190875A priority patent/CN1069635C/zh
Priority to CA002176012A priority patent/CA2176012C/en
Priority to AU34856/95A priority patent/AU700544B2/en
Priority to DE69513140T priority patent/DE69513140T2/de
Publication of KR960010617A publication Critical patent/KR960010617A/ko
Application granted granted Critical
Publication of KR100197892B1 publication Critical patent/KR100197892B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 중추신경계 치료제로서 유용한 페닐알킬아미노 카바메이트 화합물과 그의 약제학적으로 유용한 염 및 그의 제조방법에 관한 것으로서, 좀 더 상세하게는 특히 항우울제 및 항불안제로서 유용한 O-카바모일 페닐알라니놀 라세미체와 그의 순수한 D- 및 L-광학이성질체, 이들의 약제학적으로 유용한 염 및 이들을 제조하는 방법에 관한 것이다.

Description

신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 하기 구조식(Ⅰ)로 표시되는 O-카바모일-(D/L)-페닐알라니놀 화합물과 그의 약제학적으로 유용한 염.
  2. 하기 구조식(Ⅱ)로 표시되는 O-카바모일-(D)-페닐알라니놀 화합물과 그의 약제학적으로 유용한 염.
  3. 하기 구조식(Ⅲ)으로 표시되는 O-카바모일-(D)-페닐알라니놀 화합물과 그의 약제학적으로 유용한 염.
  4. 하기 구조식(Ⅳ)로 표시되는 (D/L)-페닐알라니놀을 클로로포말산 벤질에스터와 염기성 수용액하에서 반응시켜 하기 구조식(Ⅴ)로 표시되는 N-벤질옥시카보닐-(D/L)-페닐알라니놀을 합성하고, 이를 포스겐과 반응시킨 후 암모니아 수용액을 처리하여 하기 구조식(Ⅵ)로 표시되는 O-카바모일-N-벤질옥시카보닐-(D/L)-페닐알라니놀을 제조한 후, 이 (Ⅶ)화합물의 질소보호그룹인 벤질옥시카보닐을 수소화 반응에 의하여 제거하여 하기 구조식(Ⅰ)로 표시되는 O-카바모일-(D/L)-페닐알라니놀을 제조하고, 무수염산으로 에테르 용액하에서 처리하여 하기 구조식(Ⅶ)로 표시되는 O-카바모일-(D/L)-페닐알라니놀 염산염을 제조하는 것을 특징으로 하는 하기 구조식(Ⅰ)로 표시되는 O-카바모일-(D/L)-페닐알라니놀 화합물과 그의 약제학적으로 유용한 염의 제조방법.
  5. 하기 구조식(Ⅳ')로 표시되는 (D)-페닐알라니놀을 클로로포말산 벤질에스터와 염기성 수용액하에서 반응시켜 하기 구조식(Ⅴ')로 표시도는 N-벤질옥시카보닐-(D)-페닐알라니놀을 합성하고, 이를 포스겐과 반응시킨 후 암모니아 수용액으로 처리하여 하기 구조식(Ⅵ')로 표시되는 O-카바모일-(D)-페닐알라니놀을 제조한 후, 이 (Ⅵ')화합물의 질소보호그룹인 벤질옥시카보닐을 수소화 반응에 의하여 제거하여 하기 구조식(Ⅱ)로 표시되는 O-카바모일-(D)-페닐알라니놀을 제조하고, 무수염산으로 에테르 용액하에서 처리하여 하기 구조식(Ⅶ')로 표시되는 O-카바모일-(D)-페닐알라니놀 염산염을 제조하는 것을 특징으로 하는 하기 구조식(Ⅱ)로 표시되는 O-카바모일-(D)-페닐알라니놀 화합물과 그의 약제학적으로 유용한 염의 제조방법.
  6. 하기 구조식(Ⅳ″)로 표시되는 (L)-페닐알라니놀을 클로로포말산 벤질에스터와 염기성 수용액학에서 반응시켜 하기 구조식(Ⅴ″)로 표시되는 N-벤질옥시카보닐-(L)-페닐알라니놀을 합성하고, 이를 포스겐과 반응시킨 후 암모니아 수용액으로 처리하여 하기 구조식(Ⅵ″)로 표시되는 O-카바모일-N-벤질옥시카보닐-(L)-페닐알라니놀을 제조한 후, 이 (Ⅵ″)화합물의 질소보호그룹인 벤질옥시카보닐을 수소화반응에 의하여 제거하여 하기 구조식(Ⅲ)으로 표시되는 O-카바모일-(L)-페닐알라니놀을 제조하고, 무수염산으로 에테르 용액하에서 처리하여 하기 구조식(Ⅶ″)로 표시되는 O-카바모일-(L)-페닐알라니놀 염산염을 제조하는 것을 특징으로 하는 하기 구조식(Ⅲ)으로 표시되는 O-카바모일-(L)-페닐알라니놀 화합물과 그의 약제학적으로 유용한 염의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940022798A 1994-09-09 1994-09-09 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 KR100197892B1 (ko)

Priority Applications (11)

Application Number Priority Date Filing Date Title
KR1019940022798A KR100197892B1 (ko) 1994-09-09 1994-09-09 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
RU96113126/04A RU2104266C1 (ru) 1994-09-09 1995-09-06 Карбаматы фенилалкиламиноспиртов и способы их получения
PCT/KR1995/000114 WO1996007637A1 (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
EP95931444A EP0728129B1 (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
ES95931444T ES2140703T3 (es) 1994-09-09 1995-09-06 Nuevos carbamatos de fenilalquilamino-alcohol y procedimiento para su preparacion.
JP8509386A JP2680478B2 (ja) 1994-09-09 1995-09-06 新規のフェニルアルキルアミノアルコールカルバメートとその製造方法
US08/619,657 US5955499A (en) 1994-09-09 1995-09-06 Phenylalkylaminoalcohol carbamates and process for preparing the same
CN95190875A CN1069635C (zh) 1994-09-09 1995-09-06 新的氨基甲酸苯基烷基氨基醇酯及其制备方法
CA002176012A CA2176012C (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
AU34856/95A AU700544B2 (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
DE69513140T DE69513140T2 (de) 1994-09-09 1995-09-06 Neue phenylalkylaminoalkohol-carbamate und ein verfahren zu ihrer herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940022798A KR100197892B1 (ko) 1994-09-09 1994-09-09 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법

Publications (2)

Publication Number Publication Date
KR960010617A true KR960010617A (ko) 1996-04-20
KR100197892B1 KR100197892B1 (ko) 1999-06-15

Family

ID=19392447

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940022798A KR100197892B1 (ko) 1994-09-09 1994-09-09 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법

Country Status (11)

Country Link
US (1) US5955499A (ko)
EP (1) EP0728129B1 (ko)
JP (1) JP2680478B2 (ko)
KR (1) KR100197892B1 (ko)
CN (1) CN1069635C (ko)
AU (1) AU700544B2 (ko)
CA (1) CA2176012C (ko)
DE (1) DE69513140T2 (ko)
ES (1) ES2140703T3 (ko)
RU (1) RU2104266C1 (ko)
WO (1) WO1996007637A1 (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0173862B1 (ko) * 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
US20030069630A1 (en) * 2001-03-02 2003-04-10 Robert Burgermeister Stent with radiopaque markers incorporated thereon
MX2007005172A (es) * 2004-10-28 2007-06-22 Sk Corp Terapia adjunta para la depresion.
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
EP1893291B1 (en) * 2005-06-22 2010-03-03 SK Holdings Co., Ltd. Treatment of sexual dysfunction
MX2009003926A (es) * 2006-10-13 2009-06-26 Janssen Pharmaceutica Nv Composiciones de fenilalquilamino-carbamato.
US8642772B2 (en) * 2008-10-14 2014-02-04 Sk Biopharmaceuticals Co., Ltd. Piperidine compounds, pharmaceutical composition comprising the same and its use
WO2011005473A2 (en) 2009-06-22 2011-01-13 Shionogi Pharma, Inc. Methods for treating or preventing fatigue
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
MX350745B (es) 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
AU2010316106B2 (en) 2009-11-06 2015-10-22 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
JP6530741B2 (ja) 2013-03-13 2019-06-12 エアリアル，バイオファーマ，エルエルシー カタプレキシーの治療
DK3021838T3 (da) 2013-07-18 2020-08-24 Jazz Pharmaceuticals Ireland Ltd Behandling af fedme
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
TWI655179B (zh) * 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
KR102513800B1 (ko) * 2016-09-06 2023-03-24 에스케이바이오팜 주식회사 (r)-2-아미노-3-페닐프로필 카바메이트의 용매화물 폼
US10195151B2 (en) * 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102616545B1 (ko) 2016-10-06 2023-12-26 재즈 파마슈티칼즈 아일랜드 리미티드 카바모일 페닐알라닌올 화합물 및 이의 용도
WO2018133703A1 (zh) * 2017-01-20 2018-07-26 苏州科睿思制药有限公司 R228060 盐酸盐的晶型及其制备方法和用途
AU2018278332B2 (en) 2017-06-02 2022-05-19 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
CA3071779A1 (en) 2017-07-31 2019-02-07 Jazz Pharmaceuticals Ireland Limited Carbamoyl phenylalaninol analogs and uses thereof
EP3837239A4 (en) 2018-08-14 2022-05-18 Glenmark Life Sciences Limited PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF
WO2021001457A1 (en) 2019-07-04 2021-01-07 Sandoz Ag Crystalline (r)-2-amino-3-phenylpropylcarbamate acid addition salts
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
IT202000013855A1 (it) 2020-06-10 2021-12-10 Flamma Spa Un processo per la purificazione del (r)-2-ammino-3-fenilpropil carbammato
KR102390194B1 (ko) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1434826A (en) * 1973-11-14 1976-05-05 Gallardo Antonio Sa Esters and carbamates of aminoalkanols

Also Published As

Publication number Publication date
AU700544B2 (en) 1999-01-07
CA2176012C (en) 1999-01-05
AU3485695A (en) 1996-03-27
DE69513140D1 (de) 1999-12-09
US5955499A (en) 1999-09-21
RU2104266C1 (ru) 1998-02-10
KR100197892B1 (ko) 1999-06-15
CN1135209A (zh) 1996-11-06
ES2140703T3 (es) 2000-03-01
EP0728129B1 (en) 1999-11-03
CN1069635C (zh) 2001-08-15
DE69513140T2 (de) 2000-08-17
JPH09503231A (ja) 1997-03-31
WO1996007637A1 (en) 1996-03-14
JP2680478B2 (ja) 1997-11-19
EP0728129A1 (en) 1996-08-28
CA2176012A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
KR960010617A (ko) 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
KR910009712A (ko) 세펨 화합물 및 이의 제조방법
KR910011891A (ko) 펩티드 화합물, 이의 제조방법 및 이를 함유하는 약학적 조성물
KR880003974A (ko) 디아민의 선택적 아미딘화 방법
KR860007207A (ko) 페닐 카르바메이트 및 이것의 염을 제조하는 방법
JPS59205350A (ja) カルボキシアルキルペプチド誘導体
OA08182A (fr) Nouveaux dérivés peptidiques à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
KR890005100A (ko) 이미다조피리딘 화합물 및 이의 제법
KR860006452A (ko) 피페리딘 화합물의 제조 방법
US4535167A (en) Chiral, N-protected, N-substituted α-amino acids
DE3677798D1 (de) Aminosaeurederivate und deren verfahren zur herstellung.
KR940014435A (ko) 15-데옥시스퍼구알린 동족체, 그의 제조방법 및 치료학적 용도
ATE165810T1 (de) N-substituierte derivate des n-methyl-3-(p- trifluormethylphenoxy)-3-phenylpropylamins und verfahren zu deren herstellung
KR920014777A (ko) 치환된1,2,3,4-테트라하이드로사이클로펜트[b]인돌 1,2,3,3a,4,8a-헥사하이드로사이클로펜트[b]인돌 및 관련 화합물, 이의 중간체 및 제조방법 및 약제로서의 이의용도
KR940003953A (ko) 1. 4-벤조디옥산 유도체
EP0255807B1 (en) N-alkylamides of d-(+) -carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same
KR930016423A (ko) 헤테로사이클릭 유도체
KR960022498A (ko) 에스큘레틴 유도체, 그의 제조방법 및 약학조성물
KR910016691A (ko) 신규한 치환된-아민 화합물 및 그의 제조방법
KR900011724A (ko) 특정 피롤릴페닐-치환된 하이드록삼산 유도체
PT85869A (en) Process for preparing amino acid derivative anti-convulsant
KR960029312A (ko) N-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
KR950032097A (ko) 15-데옥시스페르구아린 유사체, 이들의 제조방법 및 치료학적인 용도
PT86250B (pt) Processo de preparacao de derivados da 2-aminoacetamida
KR920701144A (ko) 아미노산 유도체

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130109

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20140212

Year of fee payment: 16

EXPY Expiration of term